Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Hepatocellular carcinoma risk decreases as time accrues following hepatitis C virus eradication

Alimentary Pharmacology & Therapeutics(2023)10.1111/apt.17802Source: DataRank Database

Hepatocellular carcinoma risk decreases as time accrues following hepatitis C virus eradication is a research paper published in Alimentary Pharmacology & Therapeutics (2023). On theSindex it has a DataRank of 0. It has been cited 20 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access20 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 2.89)OA: hybridTopics (51)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (7)

Nicole J. Kim ORCID,Andrew M. Moon ORCID,Kay M. Johnson ORCID,Kristin Berry ORCID,Pamela K. Green

Live enrichment

PubMed:37955206 OpenAlex:https://openalex.org/W4388632417

Health Services Research and Development

Grant: I01HX003062

CSRD VA

Grant: I01 CX001156

NCI NIH HHS

Grant: R01 CA196692

FWCI

2.89

Citation Percentile

0.9%

Citation Trend

2024

2025

2026

hybridLicense: cc-by

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/apt.17802

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/apt.17802

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1111/apt.17802

journalhttps://doi.org/10.1111/apt.17802

repositoryhttps://pubmed.ncbi.nlm.nih.gov/37955206

Fields of Study

Hepatitis C virus researchHepatocellular Carcinoma Treatment and PrognosisLiver Disease Diagnosis and TreatmentHumansMaleMiddle AgedFemaleCarcinoma, HepatocellularLiver NeoplasmsHepacivirusRisk FactorsRetrospective StudiesCoinfectionAntiviral AgentsHepatitis CLiver CirrhosisSustained Virologic ResponseHepatitis C, Chronic

MeSH Terms

Sustained Virologic ResponseAntiviral AgentsFemaleHepatitis CCarcinoma, HepatocellularHumansLiver CirrhosisLiver NeoplasmsMaleMiddle AgedRetrospective StudiesRisk FactorsHepacivirusHepatitis C, ChronicCoinfection

Keywords

MedicineHepatocellular carcinomaInternal medicineProportional hazards modelHepatitis C virusBody mass indexIncidence (geometry)Hepatitis B virusCirrhosisHepatitis CLower riskRetrospective cohort studyGastroenterologyHazard ratioCohortImmunologyVirusConfidence interval

Sustainable Development Goals

SDG 0: Good health and well-being